Virtus LifeSci Profile

34.08
USD 0.33  0.98%
71%
100%

Virtus LifeSci Summary

Virtus LifeSci Biotech Clinical Trls ETF [BBC] is traded in USA and was established on July 19, 2018. The fund is classified under Sector category within BioShares family. Virtus LifeSci Biotech Clinical Trls ETF currently have 77.99 M in assets under management (AUM). , while the total return for the last 3 years was -0.52%.
Check Virtus LifeSci Probability Of Bankruptcy

Geographic Allocation (%)

Sector Allocation (%)

Virtus LifeSci Biotech Currency Exposure (%)

 % of ETF 
      Currency 

Target Price Odds Analysis

Odds Below 34.08HorizonTargetOdds Above 34.08
54.64%30 days 34.08 44.90%
Based on normal probability distribution, the odds of Virtus LifeSci to move above current price in 30 days from now is about 44.9% (This Virtus LifeSci Biotech Clinical Trls ETF probability density function shows the probability of Virtus LifeSci Etf to fall within a particular range of prices over 30 days) .

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Niemann Capital Management IncFund Units508.3 K16.7 M
View Virtus LifeSci Diagnostics

Virtus LifeSci Biotech Risk Profiles

Virtus LifeSci Biotech Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of seventeen. Virtus LifeSci Biotech Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Virtus LifeSci price patterns. View also all equity analysis or get more info about inverse tangent over price movement math transform indicator.

Key Fundamentals

Virtus LifeSci Against Markets

Current Ratings

Virtus LifeSci 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
1 
Equity ratings for Virtus LifeSci Biotech Clinical Trls ETF are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. Virtus LifeSci is traded on Archipelago Exchange in USA. more
NameVirtus LifeSci Biotech Clinical Trls ETF
Macroaxis Advice
InstrumentUSA Etf View All
RegionNorth America
Investment IssuerBioShares
ExchangeArchipelago Exchange
Etf FamilyBioShares
Fund CategorySector
Portfolio ConcentrationHealth Care
BenchmarkDOW
Phone888 383 0553
CurrencyUSD - US Dollar
IssuerBioShares
DescriptionVirtus LifeSci Biotech Clinical Trials ETF
Inception Date2014-12-17
BenchmarkLifeSci Biotechnology Clinical Trials Index
Entity TypeRegulated Investment Company
Asset Under Management77.99 Million
Average Trading Valume12,664
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorVirtus ETF Solutions LLC
AdvisorVirtus ETF Advisers LLC
CustodianThe Bank of New York Mellon Corporation
DistributorETF Distributors LLC
Portfolio ManagerMatthew B. Brown, Seth Kadushin
Transfer AgentThe Bank of New York Mellon Corporation
Fiscal Year EndOctober 31
ExchangeNYSE Arca, Inc.
Number of Constituents100.0
Market MakerVirtu Financial
Total Expense0.79
Management Fee0.79
Check also Trending Equities. Please also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.